Late relapse of IgM nephropathy‐associated nephrotic syndrome after repeated administration of immune checkpoint inhibitor against pulmonary adenocarcinoma
oleh: Kentaro Odani, Mitsuhiro Tachibana, Fumiaki Nogaki, Yutaka Tsutsumi
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2021-04-01 |
Deskripsi
Abstract ICPIs were effective for primary and metastatic foci of lung adenocarcinoma, but their repeated use provoked a late relapse of IgM nephropathy and lethal lesions in pancreas and lung. ICPIs should be used carefully in cases of immune‐related disease.